Advances in Early Diagnostic Markers for Hepatocellular Liver Cancer
Year: 2025
Type: article
Abstract: Hepatocellular carcinoma (HCC) is a common malignancy in China, and its incidence and lethality are increasing every year, so it is especially important to choose cost-effective diagnostic methods to achieve early diagnosis and treatment. At present, the most widely used examination measures in the world are ultrasonography of the liver and tumor marker alpha-fetoprotein (AFP), but its accuracy is limited, the research on tumor markers of HCC has been progressing rapidly in recent years, and this paper summarizes the roles and values of protein markers, enzyme and its isozymes markers, and gene markers in the identification of early hepatocellular carcinoma.
DOI: 10.54097/p1bxmg57
Authors: Mingqi Wang, Kehe Chen, Huanyao Li, Chunrou Qin
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4408933232